Spruce biosciences announces upcoming poster presentation at the pediatric endocrine society 2024 annual meeting

South san francisco, calif.--(business wire)--spruce biosciences, inc. (nasdaq: sprb), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the pediatric endocrine society (pes) 2024 annual meeting taking place may 2-5, 2024, in chicago, il. in the poster presentation, paul thornton, m.b.b.s., will highlig.
SPRB Ratings Summary
SPRB Quant Ranking